-
'I'll adapt': First pregnant candidate navigates French presidential race
-
China, Indonesia hold talks on security, defence
-
Hong Kong convicts Tiananmen vigil activists of inciting subversion
-
Train to nowhere? South Korea's lonely push for peace with the North
-
The Hong Kong Tiananmen vigil activists convicted in national security trial
-
Australia's Hussey mulls role with England for Ashes series
-
Eel-powered Japan whizz-kid, 11, chases Asian Games history
-
Indian captain 'scapegoat' in Britain's Russia shadow fleet case, wife says
-
Asian markets extend rally as traders assess US Treasuries pledge
-
Rosenior seeks to match Paris FC's capital ambition as Ligue 1 returns
-
Barcelona enter new era as Flick targets La Liga hat-trick
-
Inter set for Serie A title defence as Milan get Amorim reboot
-
Pogacar favourite for Vuelta with Grand Tour treble in sight
-
'Greatest' Springboks face All Blacks in clash of juggernauts
-
Bangladesh coach Simmons wary of Australia backlash in second Test
-
William and Harry: Britain's warring royal brothers
-
Hong Kong Tiananmen activists to receive national security verdict
-
UN holds second informal poll for next leader
-
Who are the candidates vying to lead the UN?
-
In US mining hub, black lung rates soar
-
Swiatek into Cincinnati semis after Rybakina injury
-
Champions Arsenal embrace being 'hunted' as Premier League returns
-
University suspends academic behind Jason Arday plagiarism charges
-
World No.2 Rybakina retires from Cincinnati clash with Swiatek
-
Key European leaders demand Israel halt West Bank settlement project
-
'I heard you missed me': Melania Trump jokes about month out of spotlight
-
McIlroy bounces back to share BMW Championship lead
-
Amazon Prime Video to invest $2 bn in Latin America productions
-
Cobolli fueled by candy in sweet defeat of Paul
-
Panama Canal to reduce shipping over El Nino-fueled drought
-
Jailed Pakistan ex-PM Khan moved to hospital on court order: party
-
Maradona trial on hold over possible medical evidence mix-up
-
Pogacar eyes 'missing' piece ahead of Vuelta return
-
'Green dilemma': China's solar boom hurt birds, says study
-
US, Canada 'very close' to trade deal, Ottawa says, as details emerge
-
Pegula hangs on to dispatch Anisimova, reach Cincinnati semi-finals
-
Ronaldinho returns in search of 'beautiful' 300th goal
-
US charges woman with IS-inspired plot to blow up New York State Capitol
-
US pushes allies, China to back Trump's economic war on Iran
-
What a record-breaking El Nino could mean for the world
-
Former NBA MVP Harden reportedly set to return to Cavaliers
-
Duplantis edges Karalis to win Lausanne Diamond League pole vault
-
Brook makes Pakistan pay for drop as England dominate first Test
-
Alcaraz to return for US Open title defence
-
MemeCore Arrives on Nasdaq Through $1 Billion Landmark Treasury Transaction
-
China's rapid solar expansion hurt bird diversity: study
-
First US deportees land in Liberia
-
President Paul Biya back in Cameroon after 73 days away
-
US, Canada resume talks to finalize trade deal as details emerge
-
Newcastle boss Jaissle unfazed by lack of respect
Thriving scorpion population is stinging problem for Brazil
Forget snakes, it's scorpions Brazilians most need to worry about.
The arachnids -- feared for the toxic stinger poised atop their tails -- are proliferating thanks to urbanization and warming temperatures.
The result is that scorpions have become the most lethal poisonous animal in Brazil, posing a growing danger for people across the whole country -- and spurring demand for antivenom.
The most widely found species in the country, the Brazilian yellow scorpion, is the most dangerous scorpion in South America.
Unusually for scorpions, this all-female species also reproduces asexually, reducing population-control options.
"With a warming habitat, these animals' metabolisms are also warming, so they are more active, eating more and reproducing more," explained Thiago Chiariello, production coordinator of the scorpion antivenom lab at Brazil's Instituto Butantan in Sao Paulo.
Add to that rampant urbanization which both scares away scorpions' natural predators such as lizards and birds while boosting the number of available cockroaches -- tasty meals for the arachnids -- and the problem is evident.
"Cities are growing unchecked" and the spread of trash they bring means more food supply for scorpions, Chiariello said.
"This is leading to more contact with people, which means more accidents."
- Soaring sting numbers -
Last year -- the latest dataset available -- there were 152 deaths from scorpion stings in Brazil, compared with 140 from snakebites. That was an increase from 2019, when 95 deaths by scorpion sting were recorded.
According to Brazil's health ministry, there were more than 200,000 scorpion sting incidents registered last year -- 250 percent more than a decade earlier, and an average of nearly 550 stings per day.
Healthy adults might get mild to moderate symptoms from a Brazilian yellow scorpion sting, including pain, vomiting, profuse sweating and tremors.
But there are more severe symptoms -- including shock, fluid build-up in the lungs, cardiovascular collapse and heart failure -- that can prove deadly, especially for children and the elderly.
- Life-saving antivenom -
That makes the Butantan institute's antivenom very important.
Chiariello's team carry out their serum-making task in making that serum with extreme precision.
They first use tweezers to guide a live scorpion's stinger into a container.
The poison is then injected into horses, which are less vulnerable to the toxin's effects than humans, and which produce more antibodies.
"There is a whole purification process in the horses' blood," explained Paulo Goldoni, a biologist at the institute.
"The serum is the only way to save lives," he said.
Last year saw more than 11,000 people in Brazil receive scorpion antivenom, mostly in the country's heavily populated southeast, according to authorities.
With serum demand growing, but also the number of available scorpions, the Instituto Butantan has a steady supply of venom donors.
"If ever there was a lack of serum, we would certainly see a serious increase in the number of deaths," the biologist said.
F.AbuZaid--SF-PST